Conduit Pharmaceuticals Inc. (CDT)

NASDAQ: CDT · IEX Real-Time Price · USD

0.238

-0.022 (-8.56%)

At close: Jul 19, 2024, 4:00 PM

0.235

-0.003 (-1.30%)

Pre-market: Jul 22, 2024, 7:28 AM EDT

Conduit Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	6.42	5.17	3.05	2.89
Research & Development	0.22	0.09	0.04	0.03
Other Operating Expenses	0	0	0.07	0.26
Operating Expenses	6.64	5.26	3.16	3.17
Operating Income	-6.64	-5.26	-3.16	-3.17
Interest Expense / Income	0.29	0.21	0	0
Other Expense / Income	-4.63	-4.94	1.73	0.48
Pretax Income	-2.3	-0.54	-4.89	-3.66
Net Income	-2.3	-0.54	-4.89	-3.66
Shares Outstanding (Basic)	74	67	37	1,000
Shares Outstanding (Diluted)	74	68	37	1,000
Shares Change	14.24%	81.30%	-96.26%	-
EPS (Basic)	-1254.99	-0.01	-0.13	-3657.00
EPS (Diluted)	-7310.98	-6056.00	-4887.00	-3657.00
Free Cash Flow	-8.11	-7.73	-2.27	-2.15
Free Cash Flow Per Share	-0.11	-0.12	-0.06	-0.00
EBITDA	-2.01	-0.32	-4.89	-3.66
EBIT	-2.01	-0.32	-4.89	-3.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).